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a  b  s  t  r  a  c  t
Extract  obtained  from  the  leaves  of  Musanga  cecropioides  R.  Br.  ex Tedlie,  Urticaceae,  a tree  growing  in
Africa,  is  used  traditionally  in the  treatment  of edema  and  rheumatism.  The  anti-inﬂammatory  and  anti-
nociceptive  properties  of  ethanol  extract  were  studied  using  the  carrageenan,  histamine,  serotonin  and
xylene-induced  edema  tests  as well  as the  formalin,  mouse  writhing  and  tail clip  tests.  Signiﬁcant  dose
dependent  inhibition  was  observed  in  the  carrageenan  model  with  peak  inhibition  at  150 mg/kg  (71.43%,
90  min,  p < 0.001).  In  the  histamine  and  serotonin  models,  the  extract  caused  signiﬁcant  inhibition  of
83.33%  (p <  0.05)  and  45%  (p <  0.01)  at 120  min  respectively.  For  the xylene  model,  the  extract  showed
maximum  inhibition  (59.25%)  at 200  mg/kg.  Also,  M. cecropioides  produced  signiﬁcant  anti-nociceptivehenol
lavonoid
ineral content
activity  in the mouse  writhing  (55.12%,  p  < 0.01),  formalin  (81.88%,  p < 0.01)  and  tail clip  (11.78%,  p  <  0.001)
tests  at  200  mg/kg  respectively.  The  results  obtained  in  this  study  demonstrated  that  the  ethanolic  leaf
extract  of  M. cecropioides  possesses  anti-inﬂammatory  effect  possibly  mediated  via histaminergic  and
serotonergic  inhibition  and  anti-nociceptive  effect  mediated  via  peripheral  mechanism  with  mild  central
involvement.
© 2015  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Musanga cecropioides R. Br. ex Tedlie, Urticaceae, is a decidu-
us or evergreen, dioecious medium-sized tree of up to 30 m tall
ith an umbrella-shaped crown. Traditionally, the leaves are used
o prepare a vaginal douche for painful menstruation and also used
n the treatment of gonorrhea and cough (Burkill, 1985; Ayinde
t al., 2003). The bark decoction is taken to treat arterial hyper-
ension, constipation, pain during childbirth, cough, diabetes and
chizophrenia. The stem sap is used to treat dysmenorrhoea and as
alactagogue, while the root sap is used to treat stomach spasms,
iarrhea, gonorrhea, pulmonary complaints, trypanosomiasis, skin
iseases, otitis, rheumatism, edema, epilepsy, and to ease child-
irth. The root bark is eaten with kolanut to cure cough, and the
ark is tied on wounds where it is said to effect a cure (Adejuwon,
001). The sheath-like stipules are applied as emmenagogue and
xytocic, and to treat stomach complaints, hiccough and wounds
Burkill, 1985).
∗ Corresponding author.
E-mail: asowemimo@unilag.edu.ng (A. Sowemimo).
http://dx.doi.org/10.1016/j.bjp.2015.07.022
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier EditoraPharmacological activities such as the uterotonic, antidiabetic,
hypotensive and hypoglycemic properties of the leaf and stem bark
as well as the antimicrobial activity of the root sap of M. cecropioides
have been reported (Kamanyi et al., 1992, 1996; Dongmo et al.,
1996; Ayinde et al., 2003, 2006; Adeneye et al., 2006, 2007; Senjobi
et al., 2012; Uwah et al., 2013). There is, however, no record of the
anti-inﬂammatory or analgesic activity in literature; hence, the aim
of this work is to investigate the anti-inﬂammatory and analgesic
properties of the plant with a view to validating its ethno-medicinal
use.
Materials and methods
Plant collection and extraction
The leaves of Musanga cecropioides R. Br. ex Tedlie, Urticaceae,
leaves were collected at Abatadu, Oke-ode, a village about 3 km to
Ikere, Osun State, Nigeria (7◦30′ N 4◦30′ E), in February, 2013. The
plant specimen was identiﬁed and authenticated at the Herbarium
of the Department of Botany and Microbiology, University of Lagos,
Akoka, Lagos, Nigeria where a voucher specimen (LUH 5637) was
deposited. The leaves were pulverized and macerated with absolute
 Ltda. All rights reserved.
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thanol at room temperature. The extract was ﬁltered and concen-
rated using the rotary evaporator (Buchi, Switzerland). The yield
as 4.58% (w/w).
nimals
Wistar rats (100–200 g) and Swiss albino mice (18–30 g) of
ither sex used in this study were purchased from the Animal House
f the National Agency for Food and Drug Administration and Con-
rol (NAFDAC), Lagos. The animals were maintained under standard
aboratory conditions (12 h light/dark cycle at 22 ± 2 ◦C) and fed
tandard rodent pellets (Livestock Feed PLC, Lagos, Nigeria) and
ater ad libitum. The protocol was approved by the Experimen-
ation Ethics Committee of the College of Medicine, University of
agos (CM/COM/08).
cute toxicity
Acute oral toxicity assay was performed on three groups of six
ice each fasted for 12 h prior to the experiment. The plant extract
as administered at doses of 1, 2 and 3 g/kg (p.o.). The animals were
bserved for immediate signs of toxicity and mortality for 24 h and
urther observed for seven days for signs of delayed toxicity.
harmacological studies
n vivo anti-inﬂammatory activity
arrageenan-induced paw edema. Increase in the rat hind paw lin-
ar circumference induced by plantar injection of the phlogistic
gent was used as the measure of acute inﬂammation (Henriques
t al., 1987). The rats (n = 6) were administered the plant extract
50, 100, 150 and 200 mg/kg, p.o.) while the control rats received
ndomethacin (10 mg/kg p.o.) and distilled water (10 ml/kg, p.o.)
espectively. One hour after treatment, 0.1 ml  of carrageenan (1%,
/v in water) was administered into the sub-plantar tissue of
he right hind paw. The linear paw circumference was measured
mmediately before injection of the phlogistic agents and at 30 min
nterval for 3 h using the cotton thread method (Bamgbose and
aomesi, 1981).
Anti-inﬂammatory activity is determined by analyzing the
eduction in edema size and calculating % inhibition of edema. A
ean reduction in edema when compared with control and an
ncrease % inhibition in the treated groups is an indication of anti-
nﬂammatory activity.
erotonin and histamine induced rat paw edema. In order to
lucidate the mechanism of action of M.  cecropioides, selected anti-
nﬂammatory mediators (histamine and serotonin) were used. The
ose which gave maximum inhibition in the carrageenan assay for
as used for the tests.
Adult rats (100–200 g) fasted overnight were divided into
hree groups of six animals each. Distilled water, 10 ml/kg was
dministered to group one (control), group two received 10 mg/kg
ndomethacin and group three, 150 mg/kg M.  cecropioides. All treat-
ents were done orally. One hour post treatment, edema was
nduced by injection of 0.1 ml  serotonin or histamine (10−3 mg/ml)
nto the sub-plantar tissue of the right hind paw. The linear circum-
erences of the paws were measured using cotton thread method.
easurements were made at 0 min  and thereafter at an interval of
0 min  for 3 h. The mean of the paw size were computed and per-
entage inhibitions were calculated (Agbaje and Fageyinbo, 2011).ylene-induced ear edema. Adult mice (18–30 g) fasted overnight
ere divided into six groups of six animals each and were treated
s follows: M.  cecropioides (50, 100, 150 and 200 mg/kg, p.o.), dexa-
ethasone (1.0 mg/kg p.o.) and distilled water (10 ml/kg p.o.). Eararmacognosia 25 (2015) 506–512 507
edema was induced by applying 0.03 ml  of xylene to the inner
surface of the right ear. The left ear was  considered as control. Fif-
teen minutes after the application of xylene, the mice were killed
under ether anesthesia and both ears were removed and weighed.
Increase in weight caused by the irritant was measured by sub-
tracting the weight of the untreated left ear section from that of
the treated right ear sections (Nùn˜ez Guillén et al., 1997).
Anti-nociceptive activity
Mouse writhing test. Mice used for this experiment were divided
into ﬁve groups of six animals each. Group I was given distilled
water (10 ml/kg, p.o.); Group II received the standard drug acetyl-
salicylic acid (100 mg/kg, p.o.) while the remaining Groups III, IV
and V were given the plant extract (50 mg/kg, 100 mg/kg and
200 mg/kg, p.o.) respectively. Sixty minutes after treatment, acetic
acid (0.6% v/v in saline, 10 ml/kg i.p.)  was  administered. The number
of writhes (characterized by contraction of the abdominal muscula-
ture and extension of the hind limbs) was  counted for 30 min  (Singh
and Majumdar, 1995; Mbagwu and Anene, 2007).
Formalin test. In this study, the animals (n = 6) were arranged into
ﬁve groups which received distilled water (10 ml/kg), extract (50,
100 and 200 mg/kg) and morphine (10 mg/kg s.c.) respectively. For
the induction of pain, formalin (20 l of 1% solution) was injected
into sub-plantar tissue of the right hind paw of each mouse 60 min
after administration for the oral route and 30 min  for the subcuta-
neous route. The nociceptive response was  considered as the time
spent in licking and biting of the injected paw. The responses of the
mice were observed for 5 min  (ﬁrst phase) and 15–30 min  (second
phase) post formalin injection (Shibata et al., 1989; Vianna et al.,
1998).
Haffner’s tail clip test. Mice used in this experiment were pre-
screened by placing a metal artery clip 1 in. from the base of the
tail and animals which did not respond to the clip placement by
turning or biting at the clip within 10 s were discarded. Eligible
mice were divided into ﬁve groups of ﬁve animals each. The pre-
treatment reaction time of all mice to clip was determined after
which the animals were treated as follows: Group 1: distilled water
(10 ml/kg), Groups 2, 3 and 4 were treated with the extract at
50 mg/kg, 100 mg/kg and 200 mg/kg respectively, Group 5: Mor-
phine 10 mg/kg s.c. The presence or absence of anti-nociceptive
activity was  determined 60 min  after drug administration for
oral administration and 30 min  for subcutaneous administration
(Adeyemi et al., 2004). A post-treatment cut-off time of 30 s was
used (Adeyemi et al., 2004; Agbaje and Adeneye, 2008).
Quantitative analysis
Determination of total phenol content
The total phenolic content of the extract was determined by
the modiﬁed Folin-Ciocalteu method (Wolfe et al., 2003). Gal-
lic acid was  used as a standard with a concentration range of
0.01–0.05 mg/ml  prepared in methanol (Folin and Ciocalteu, 1927).
The extract (0.5 ml)  (0.1 mg/ml) together with the gallic acid was
mixed with 2.5 ml  Folin–Ciocalteu reagent (previously diluted with
distilled water 1:10, v/v) and 2 ml  (75 g/l) of sodium carbonate. The
mixtures were vortexed for 15 s and allowed to stand for 30 min  at
room temperature before the absorbance was measured at 765 nm
using a spectrophotometer. All determinations were performed in
triplicates. The total phenolic content was expressed as mg  gallic
acid equivalent (GAE) per gram of sample.Determination of total ﬂavonoid content
Total ﬂavonoid was estimated using the method of Miliauskas
et al. (2004). A 2% AlCl3 in ethanol (2 ml) was  added to 2 ml  of
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he sample. To obtain the calibration curve, a concentration range
f 0.01–0.05 mg/ml  was used for quercetin. The absorbance was
easured at 420 nm after 60 min  at room temperature. The total
avonoid content was calculated as milligram quercetin equivalent
QE) per gram of sample.
etermination of mineral content
Powdered leaf sample (1 g) was digested using 10 ml  of 1 M
NO3. The solution was then ﬁltered and made up to 50 ml  with
istilled water. Concentrations of sodium, potassium, zinc, cop-
er, calcium, magnesium, iron and manganese were determined by
tomic absorption spectrophotometry (Analyst 200, Perkin Elmer,
altham, MA,  USA).
tatistical analysis
All values were expressed as means ± SEM. Results were
nalyzed by one-way ANOVA followed by Dunnett’s multiple com-
arison or by two-way ANOVA followed by Bonferroni test using
raph Pad Prism 6. Results were considered statistically signiﬁcant
t p < 0.05, p < 0.01, p < 0.001.
esults
cute toxicity test
The ethanol leaf extract of M.  cecropioides was found safe at the
oses tested (1, 2, 3 g/kg). During the seven days assessment time,
he test animals were found normal with no visible signs of delayed
oxicity.
nti-inﬂammatory activity
arrageenan-induced rat paw edema test
The leaf extract of M.  cecropioides (50, 100, 150 and 200 mg/kg)
roduced a signiﬁcant (p < 0.05, p < 0.01, p < 0.001) inhibition of
dema relative to control (10 ml/kg distilled water) in a dose inde-
endent manner. The highest inhibition of edema was  obtained
ith 150 mg/kg dose (71.43%) of the extract at 90 min  (Table 1).
he extract compared effectively with standard drug indomethacin
10 mg/kg) used in this study, which produced a peak inhibition of
dema (68.47%) at 30 min.
nﬂammatory mediators
erotonin-induced and histamine-induced rat paw edema
In the serotonin model, the extract of M.  cecropioides at a dose of
50 mg/kg gave a mild inhibitory effect (45.0%) at 120 min  while the
tandard produced a more pronounced inhibitory (64.52%) effect
t 150 min  (Fig. 1A). For the histamine model, at the same dose of
xtract, there was a peak inhibitory effect (83.33%) relative to the
ontrol (distilled water 10 ml/kg) observed at 120 min. The extract
as more effective than the standard (indomethacin 10 mg/kg)
hich also produced a peak inhibitory effect (57.14%) at the same
ime with the extract (Fig. 1B).
ylene-induced ear edema
Animals pre-treated with ethanolic leaf extract of M.  cecropi-ides (50, 100, 150 and 200 mg/kg) produced a signiﬁcant (p < 0.05)
nhibition of edema (Table 2). The effect produced was  dose
ependent and compared effectively with the standard drug dexa-
ethasone (1 mg/kg) used in the study. Ta
b
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Fig. 1. The effects of Musanga cecropioides (MC) and indomethacin on rat hind paw
edema induced by (A) serotonin and (B) histamine. Data represented as mean ± SEM
(n  = 6). *p < 0.05, **p < 0.01 and ***p < 0.001 compared to the control (one-way ANOVA
followed by Dunnett’s multiple comparison).
Table 2
Effect of Musanga cecropioides on xylene induced ear edema.
Treatment Dose (mg/kg) Increase in ear weight
(mg)
% Inhibition
M.  cecropioides 50 12.83 ± 0.003 34.63
M.  cecropioides 100 13.00 ± 0.004 33.79
M.  cecropioides 150 11.00 ± 0.006 43.96
M.  cecropioides 200 8.00 ± 0.002* 59.25
Dexamethasone 1 4.80 ± 0.002* 75.55
Distilled water 10 ml/kg 19.63 ± 0.004 –
Values are expressed as mean ± SEM (n = 6).
* p < 0.05 vs. control (one-way ANOVA, Dunnett’s multiple comparison test).
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Fig. 2. Effect of Musanga cecropioides (MC) on mouse writhing test in mice. Values
are expressed as mean ± SEM (n = 6). *p < 0.01 compared to the control (one-way
ANOVA followed by Dunnett’s multiple comparison).
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First phase Second phase
latency of 3.17 ± 0.52 s. The ethanolic leaf extract of M.  cecro-
pioides (200 mg/kg) produced a signiﬁcant (p < 0.01) increase innti-nociceptive activity
ouse writhing test
Writhing reﬂex was produced by intraperitoneal injection of
cetic acid in control animals with 107.3 ± 14 number of writhes
ounted in 30 min. The plant extract (50, 100, 200 mg/kg) pro-
uced a signiﬁcant (p < 0.01) reduction in the number of writhes
n a dose dependent manner. The peak inhibitory effect (55.12%)
as produced at the dose of 200 mg/kg. The standard drug (Aspirin,
00 mg/kg) also produced a signiﬁcant (73.30%, p > 0.01) reduction
n the number of writhes with a greater inhibition compared to the
xtract (Fig. 2).Fig. 3. Effect of Musanga cecropioides (MC) on formalin induced reﬂex in mice. Data
represented as mean ± SEM (n = 6). *p < 0.05, **p < 0.01 and ***p < 0.001 compared to
the  control (two-way ANOVA followed by Bonferroni multiple comparison).
Formalin test
Injection of formalin into the sub-plantar tissue of the right
hind paw of control mice in the ﬁrst phase produced nocicep-
tive response of biting and licking of the paw with duration of
116 ± 26.98 s. The plant extract (50, 100, 200 mg/kg) produced a
statistically signiﬁcant (p < 0.05, p < 0.01, p < 0.001) dose depend-
ent inhibition of nociceptive reaction with peak effect produced
(66.81%) at a dose of 200 mg/kg. Morphine produced a greater
inhibitory response (100%). In the second phase, the duration of
the nociceptive reaction in the control group was  151.8 ± 41.3. The
extract, in a dose dependent manner, signiﬁcantly inhibited noci-
ceptive reaction with peak effect (81.88%) at 200 mg/kg. In this
phase, the effect produced by the extract compared effectively with
morphine (96.4%) (Fig. 3).
Haffner’s tail clip test
Application of the metal artery clip unto the tail of animals in the
control group elicited reactions toward clip removal with the post-
treatment latency being 3.18 ± 0.86 s, 5.04 ± 0.63 s and 1.17 ± 1.11 s
measured at 60, 90, and 120 min, respectively, with a pre-treatmentreaction latency time with peak effect (17.02% inhibition) at 90 min
510 A. Sowemimo et al. / Revista Brasileira de Farmacognosia 25 (2015) 506–512
Table  3
The effects of Musanga cecropiodes on tail clip reﬂex in mice.
Treatment Dose (mg/kg) Pre-treatment latency period Post treatment latency period
60 min  90 min  120 min
M.  cecropiodes 50 3.061 ± 0.84 6.14 ± 0.64 (5.418) 8.74 ± 2.02 (9.97) 6.25 ± 0.79 (5.56)
M.  cecropiodes 100 3.26 ± 0.65 8.77 ± 1.51 (9.71) 10.26 ± 0.78 (12.35) 7.49 ± 1.03 (7.45)
M.  cecropiodes 200 2.94 ± 0.36 10.84 ± 1.60 (13.86)* 12.65 ± 2.27 (17.02)* 9.66 ± 0.89 (11.78)*
Morphine 10 1.95 ± 0.48 48.41 ± 8.48 (80.03)**** 45.75 ± 9.88 (75.45)**** 49.22 ± 9.05 (81.43)****
Distilled water 10 ml/kg 3.17 ± 0.52 3.18 ± 0.86 5.04 ± 0.63 1.17 ± 1.11
Values are expressed as mean ± SEM (n = 6). Figures in parenthesis represent percentage 
* p < 0.01 vs. control group (two-way ANOVA followed by Bonferroni multiple compari
**** p < 0.001 vs. control group (two-way ANOVA followed by Bonferroni multiple compar
Table 4
Mineral composition of Musanga cecropioides leaves (mg/g of dry matter).
S/n Element Concentration (mg/g)
1 Sodium (Na) 1.08
2  Potassium (K) 0.85
3  Zinc (Zn) 0.31
4  Copper (Cu) 0.0075
5  Calcium (Ca) 1.47
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p6  Magnesium (Mg) 1.06
7  Iron (Fe) 0.94
8  Manganese (Mn) 0.35
ost-treatment. This effect was mild compared to the effect pro-
uced by morphine (81.43% inhibition) at 120 min (Table 3).
uantitative analysis
The total phenolic and ﬂavonoid contents of the extract were
85.46 ± 7.44 (GAE/g of dried extract mg/g) and 255.86 ± 12.53 (QE
g/g) respectively.
ineral composition
The mineral composition of the leaves of M. cecropioides is
resented in Table 4. Of all four macro-elements (Na, K, Ca, Mg)
nvestigated, calcium occurred in the largest amount and for the
icro-elements (Zn, Cu, Mn,  Fe), iron occurred in the largest
mount.
iscussion
The use of plants as medicines predates written human history.
lants are able to synthesize a wide variety of chemical compounds
hich have beneﬁcial effects on long-term health when consumed
y humans, and can be used to effectively treat human diseases.
This study investigated the anti-inﬂammatory and anti-
ociceptive activities of M.  cecropioides. Carrageenan, xylene,
erotonin and histamine tests were used to screen the anti-
nﬂammatory activity while mouse writhing, formalin and tail clip
ests were used to evaluate the anti-nociceptive activity.
The paw edema induced by carrageenan involves several
hemical mediators such as histamine, serotonin, bradykinin,
nd prostaglandins (Vinegar et al., 1987). M.  cecropioides extract
igniﬁcantly (p < 0.001) inhibited the edema size. The effect pro-
uced by the extract compared effectively with the standard drug
indomethacin) with a peak inhibitory effect at 150 mg/kg observed
t 90 min. This result suggests that the extract of M. cecropioides is
ffective in the early phase of inﬂammation which is primarily due
o the release of histamine and serotonin.For the inﬂammatory mediators, the plant extract (150 mg/kg)
howed a signiﬁcant (p < 0.05) inhibition of serotonin compared
ith the control. The peak inhibition was obtained at 120 min
ost induction. On the other hand, the same dose of the extractinhibition.
son test).
ison test).
(150 mg/kg) showed a signiﬁcant (p < 0.05) inhibition of histamine
when compared with the control (10 ml/kg distilled water). The
peak inhibition was  obtained at 120 min. These data indicate that
the plant extract is likely to interfere with histamine release
at the initial phase of inﬂammation. Thus, it can be specu-
lated that the inhibition of edema by the extract at the early
phase of inﬂammation-induced by carrageenan may  be mediated
possibly through the inhibition of histamine. However, the differ-
ence in the time of peak inhibition observed in the carrageenan
and histamine/serotonin models maybe due to interference of
other mediators such as bradykinin, and prostaglandins which are
present when carrageenan is used in edema induction.
The xylene-induced ear edema test is useful for the evaluation
of anti-inﬂammatory steroids. The swelling induced by xylene can
cause an acute inﬂammatory response which may  lead to severe
vasodilation and plasma extravasations. This model is linked with
phospholipase A2 which is involved in the pathophysiology of
inﬂammation due to xylene (Zaninir et al., 1992; Akindele and
Adeyemi, 2007). In this study, dexamethasone, a steroidal anti-
inﬂammatory agent, produced signiﬁcant reduction in the ear
edema. The extract of M. cecropioides also signiﬁcantly (p < 0.05)
inhibited edema induced by xylene and this suggests a steroidal
anti-inﬂammatory activity of the plant possibly mediated by the
inhibition of phospholiphase A2.
Intraperitoneal injection of acetic acid elicits a response charac-
terized by a wave of abdominal musculature contraction followed
by extension of the hind limb (writhing). This response is used
to establish the peripheral and non-steroidal action of an anal-
gesic drug and is thought to involve local peritoneal receptors at
the surface of the cell lining the peritoneal cavity (Bentley et al.,
1983; Berkenkopf and Weichmann, 1988; Nùn˜ez Guillén et al.,
1997; Zakaria et al., 2008). The agent reducing the number of
writhing will render anti-nociceptive effect preferably by inhibi-
tion of prostaglandin synthesis, a peripheral mechanism of pain
inhibition (Duarte et al., 1988; Ferdous et al., 2008). Peripherally
acting drugs such as aspirin have been reported to exhibit anti-
nociceptive activity in the writhing test only (Zakaria et al., 2008).
M. cecropioides extract produced a signiﬁcant reduction in number
of writhes in this study and this suggests a peripheral mechanism
of action involving direct action on nociceptors, direct inhibition of
prostaglandin action or indirect inhibition of prostaglandin synthe-
sis by inhibition of cyclo-oxygenase (COX) activity (Franzotti et al.,
2000).
Biphasic nociceptive response is produced by subcutaneous
injection of 1% formalin into the mice right hind paw. The ﬁrst tran-
sient phase which is short lived, involves direct effect of formalin
on sensory C-ﬁbers while the second prolonged phase is associ-
ated with the development of the injury induced spinal sensation
which is responsible for facilitated pain processing. This is a central
sensitization of the dorsal horn neuron, a process which occurs dur-
ing inﬂammatory pain (Rezayat et al., 1999; Ashok et al., 2006; Da
Rocha et al.,  2011). Changes in the dorsal horn of the spinal cord are
said to be initiated by C-ﬁber barrage during the ﬁrst phase (Tjølsen
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t al., 1992). Centrally acting analgesic drugs such as morphine
nhibit both phases while peripherally acting drugs inhibit only
he latter phase (Santos et al., 1994; Chen et al., 1995; Agbaje and
deneye, 2008). Studies have shown the involvement of serotonin,
istamine, substance P, excitatory amino acid and prostaglandin
n the late phase of formalin test with bradykinin affecting both
hases (Tjølsen et al., 1992; Doak and Sawynok, 1997; Rezayat et al.,
999). M.  cecropioides inhibited both the early and the late phase of
ormalin induced pain but greater inhibition was observed in the
ate phase which compared favorably with the standard drug (mor-
hine) used in the study. Thus, suggesting more peripheral action
han central effect.
To further conﬁrm the involvement of the central mechanism
n the anti-nociceptive effect of M.  cecropioides, the tail clip test
as used. In this model, increase in the pain reaction time (latency
eriod) indicates the level of anti-nociception induced by the drug
r extract. The extract of M.  cecropioides produced a signiﬁcant
p < 0.01) dose dependent increase in pain threshold in mice. This
ffect was however mild when compared with the standard drug
morphine). Maximum inhibition of the extract was  observed at
0 min  while that of the standard was seen at 120 min. This further
onﬁrmed that the plant extract has very mild central activity.
This is the ﬁrst report of the anti-inﬂammatory and antinoci-
eptive effects of M.  cecropioides in literature. However, the
nti-inﬂammatory effect of pomolic acid isolated from Cecropia
achystachya, a member of the family Cecropiaceae has been
eported (Schinella et al., 2008).
Phenolic compounds are secondary metabolites found in plants.
n vitro and animal studies have shown that polyphenolic com-
ounds such as ﬂavonoids and phenolic acids can exert multiple
ctivities such as anti-inﬂammatory and analgesic effects (Larrosa
t al., 2010). Flavonoids have been reported to effect anti-
ociceptive activity by targeting prostaglandins (Rao et al., 1998;
ajannarayana et al., 2001). The results from this study suggest that
he extract of M.  cecropioides is rich in polyphenols and these may
e responsible for the observed biological activities.
The results from the mineral content determination by atomic
bsorption spectrophotometry revealed the presence of magne-
ium, manganese, copper, zinc, sodium, potassium, calcium and
ron. The role of magnesium in inﬂammation has been reported.
agnesium deﬁciency in rats is said to lead to the activation
f macrophages and elevation of plasma concentration of inter-
eukin (IL) 6, which is a known mediator of the acute phase
esponse (Maier et al., 1997, 2005). Manganese is reported as a
emedy for strains, sprains and inﬂammation as it has the abil-
ty to increase the level or activity of superoxide dismutase (SOD)
hereby increasing antioxidant activity (Murray, 1996). Magnesium
nd manganese block calcium channels, thereby preventing cal-
ium uptake at the presynaptic terminal and subsequent release
f synaptic transmitter hence inhibiting nociception (Abdel-Azim,
001; Giniatullin et al., 2003). Copper supplementation has been
eported to have anti-inﬂammatory effect and this is related to
ts ability to form complexes that serve as selective antioxidants
DiSilvestro and Marten, 1990). Deﬁciency of zinc has been reported
n diseases associated with chronic inﬂammation and oxidative
tress such as rheumatoid arthritis, diabetes, and cancers (Prasad,
009). It has also been reported to increase concentration of inﬂam-
atory cytokines and oxidative stress and induce apoptosis and
ndothelial cell dysfunction (Brown et al., 2002; Prasad, 2008;
verbeck et al., 2008). Reports suggest that calcium decreases
umor-promoting pro-inﬂammatory markers in the plasma of spo-
adic colorectal adenoma patients. C-reactive protein (CRP), tumor
ecrosis factor- (TNF-)  and interleukin-6 (IL-6), speciﬁc pro-
nﬂammatory markers are reported to be elevated in patients with
nﬂammatory bowel disease (Kim et al., 2008; Groblewska et al.,
008). Calcium is said to bind to bile acids and free fatty acids,armacognosia 25 (2015) 506–512 511
precipitating them from solution in the colon thereby reducing
oxidative stress and inﬂammation in the colon (Newmark and
Lipkin, 1992). It is also reported to activate the calcium sensing
receptor involved in cell-cycle events and differentiation promot-
ing cell-cell and cell-matrix adhesion (Lamprecht and Lipkin, 2001).
The presence of these elements in the extract of M.  creopioides
may  contribute to anti-inﬂammatory and anti-nociceptive effects
observed.
Conclusively, the extract of M.  cecropioides has shown anti-
inﬂammatory action mediated possibly through the inhibition of
histamine and anti-nociceptive action mediated through periph-
eral mechanism with a mild central involvement. This study
justiﬁes the traditional use of the plant in the treatment of inﬂam-
mation and painful conditions.
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